MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
12 hedge funds and large institutions have $277K invested in Stealth BioTherapeutics Corp. ADS in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-7
Holders Change %
-36.84%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Renaissance Technologies
New York
|
$30K |
2 |
Envestnet Asset Management
Chicago,
Illinois
|
$7K |
3 |
Osaic Holdings
Scottsdale,
Arizona
|
$3K |
Top Sellers
1 |
Citadel Advisors
Miami,
Florida
|
$0 |
2 |
VF
Virtu Financial
New York
|
$0 |
3 |
IC
Ikarian Capital
Dallas,
Texas
|
$134K |
4 |
HighTower Advisors
Chicago,
Illinois
|
$0 |
5 |
Millennium Management
New York
|
$0 |